
bleeding, mostly gastrointestinal.136 In this trial approximately 38% had diabetes mellitus and the beneÔ¨Åt of
the combination therapy seemed similar in those with

1126

Fitridge et al

Journal of Vascular Surgery
November 2023

and without diabetes. Given this limited evidence base
and the added treatment burden for this frequently
vulnerable cohort, a Best Practice Statement in line
with the ESVS and ADA recommendations was